9th Combined Dermatology Congress SA and Eucerin: Shaping skincare innovation

Eucerin joined the 9th Combined Dermatology Congress South Africa to showcase skincare innovations and groundbreaking epigenetic solutions.

Eucerin marked a significant presence at the 9th Combined Dermatology Congress of South Africa, held in Durban in August 2025. This prominent event brought together dermatologists, researchers and healthcare professionals to discuss cutting-edge innovations and trends shaping the future of skincare. Hosted by leading organisations, including the Dermatology Society of South Africa and Melanoma Society South Africa, the congress provided an ideal platform for collaboration and knowledge-sharing.

Science-backed solutions for skincare

Eucerin demonstrated its industry-leading expertise with pioneering advancements in epigenetic technology, including its proprietary Epicelline molecule. This innovative approach aims to combat ageing, hyperpigmentation, and overall skin health challenges. Through interactive sessions, Eucerin solidified its commitment to providing practical, clinically backed skincare solutions that elevate the well-being of patients.

Strategic highlights at the congress

• Laser Dermatology Workshop: Renowned dermatologists Dr Firas Al Niaimi and Dr Lev Naidoo explored advanced laser treatments and their practical applications in clinics.

• Epigenetics Breakfast Symposium: An engaging session that delved into how epigenetics reshapes skincare health, offering breakthrough insights for dermatology.

• Interactive Brand Booths: Eucerin’s showcase included advanced tools and tutorials that addressed skincare concerns, including environmental stress and active ingredient efficiency.

A commitment to dermatological growth

By participating in the 9th Combined Dermatology Congress, Eucerin once again cemented its reputation as a leader in science-driven skincare. Its involvement underscored its pledge to collaborate with professionals and provide cutting-edge solutions for improving skincare outcomes.